These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2128197)

  • 1. Influence of 6-OHDA lesion of central noradrenergic systems on corticosteroid receptors and neuroendocrine responses to stress.
    Maccari S; Le Moal M; Angelucci L; Mormède P
    Brain Res; 1990 Nov; 533(1):60-5. PubMed ID: 2128197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic regulation of type-I and type-II corticosteroid receptors in amygdala and hypothalamus.
    Maccari S; Piazza PV; Rouge-Pont F; Angelucci L; Simon H; le Moal M
    Brain Res; 1992 Aug; 587(2):313-8. PubMed ID: 1525664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal type I and type II corticosteroid receptors are modulated by central noradrenergic systems.
    Maccari S; Mormède P; Piazza PV; Simon H; Angelucci L; Le Moal M
    Psychoneuroendocrinology; 1992; 17(2-3):103-12. PubMed ID: 1332096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesions of the hippocampal efferent pathway (fimbria-fornix) do not alter sensitivity of adrenocorticotropin to feedback inhibition by corticosterone in rats.
    Bradbury MJ; Strack AM; Dallman MF
    Neuroendocrinology; 1993 Oct; 58(4):396-407. PubMed ID: 8284025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the hippocampal mineralocorticoid and glucocorticoid receptors in the hypothalamo-pituitary-adrenal axis of the aged Fisher rat.
    Morano MI; Vázquez DM; Akil H
    Mol Cell Neurosci; 1994 Oct; 5(5):400-12. PubMed ID: 7820364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal type I and type II corticosteroid receptors are differentially regulated by chronic prazosin treatment.
    Kabbaj M; Le Moal M; Maccari S
    Neuroscience; 1996 Aug; 73(4):963-70. PubMed ID: 8809815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of discrete lesions in the ventral noradrenergic ascending bundle on the corticotropic stress response depend on the site of the lesion and on the plasma levels of adrenal steroids.
    Gaillet S; Alonso G; Le Borgne R; Barbanel G; Malaval F; Assenmacher I; Szafarczyk A
    Neuroendocrinology; 1993 Oct; 58(4):408-19. PubMed ID: 8284026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
    Spencer RL; Kim PJ; Kalman BA; Cole MA
    Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and age-related changes in hippocampal type I and type II corticosteroid receptor binding capacity in young and aged, handled and nonhandled rats.
    Meaney MJ; Aitken DH; Sharma S; Viau V
    Neuroendocrinology; 1992 Feb; 55(2):204-13. PubMed ID: 1320217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the adrenocortical axis by surgical stress: involvement of central norepinephrine and interleukin-1.
    DeKeyser FG; Leker RR; Weidenfeld J
    Neuroimmunomodulation; 2000; 7(4):182-8. PubMed ID: 10810250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
    Ratka A; Sutanto W; Bloemers M; de Kloet ER
    Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies.
    Pacak K; Palkovits M; Kopin IJ; Goldstein DS
    Front Neuroendocrinol; 1995 Apr; 16(2):89-150. PubMed ID: 7621982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mesolimbic dopaminergic system exerts an inhibitory influence on brain corticosteroid receptor affinities.
    Casolini P; Piazza PV; Kabbaj M; Leprat F; Angelucci L; Simon H; Le Moal M; Maccari S
    Neuroscience; 1993 Jul; 55(2):429-34. PubMed ID: 8377934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor.
    Pace TW; Spencer RL
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1082-8. PubMed ID: 15671079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats.
    Boero G; Pisu MG; Biggio F; Muredda L; Carta G; Banni S; Paci E; Follesa P; Concas A; Porcu P; Serra M
    Neuropharmacology; 2018 May; 133():242-253. PubMed ID: 29407214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of prenatal stress on the rat hypothalamic-pituitary-adrenal axis activity: the role of the brain glycocorticoid receptors].
    Ordian NE; Pivina SG; Akulova VK; Galeeva AIu
    Ross Fiziol Zh Im I M Sechenova; 2006 Sep; 92(9):1100-10. PubMed ID: 17290878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin and interleukin 1 decrease the affinity of hippocampal mineralocorticoid (type I) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis.
    Schöbitz B; Sutanto W; Carey MP; Holsboer F; de Kloet ER
    Neuroendocrinology; 1994 Aug; 60(2):124-33. PubMed ID: 7969769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems.
    De Kloet ER; Reul JM
    Psychoneuroendocrinology; 1987; 12(2):83-105. PubMed ID: 3037584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.